Dale McElveen

Expanded Access Program (EAP) for Lenalidomide (Revlimid®) Plus Dexamethasone in over 1400 Subjects with Relapsed or Refractory Multiple Myeloma.

Shaji K. Kumar, D. Reece, J. Zeldis, 2006 .